Fondaparinux Sodium Synthesis via Modular Building Blocks
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing Fondaparinux sodium and related compounds are inefficient, requiring numerous steps and resulting in low yields and high costs due to complex protection and deprotection strategies, as well as contamination issues with β-methyl glucoside impurities.
Innovation Solution
Development of novel synthetic strategies involving convergent processes for the preparation of protected heparinic pentasaccharide precursors and intermediates, such as the EDC trimer and DC Building Block, which reduce the number of synthetic steps, improve yields, and minimize β-methyl glucoside contamination through Schmidt glycosylation and milder oxidation procedures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional protection and deprotection strategies are used for synthesizing Fondaparinux sodium, then the synthesis can be completed with established methods, but the process requires numerous steps resulting in low yields and high costs
Solution Approach 1:
The patent divides the pentasaccharide synthesis into modular disaccharide building blocks (DC Building Block and BA Building Block) that can be independently synthesized and then coupled. This segmentation reduces the complexity of the overall synthesis pathway and improves yield by avoiding numerous protection/deprotection steps required in traditional linear synthesis approaches.
Solution Approach 2:
The patent performs preliminary synthesis of protected disaccharide building blocks with pre-installed protecting groups in specific patterns. These pre-prepared building blocks contain the protection strategy already in place, allowing direct coupling without additional protection steps during the main synthesis pathway, thereby improving overall efficiency and yield.
2Reliability
If traditional synthesis methods are employed, then the process can be established with conventional procedures, but the number of synthetic steps is excessive and costs are high
Solution Approach 1:
The synthesis is segmented into independent building block preparation and coupling phases. The disaccharide building blocks are synthesized separately with optimized protecting group patterns, and then coupled in a final step. This segmentation reduces the total number of steps from traditional linear synthesis by eliminating redundant protection/deprotection cycles.
Solution Approach 2:
The patent employs specific parameter changes in the form of novel protecting group patterns (combining benzylidene acetal at specific positions with benzoyl and acetyl groups) that enable selective reactions and simplify the synthesis pathway. These parameter changes in protecting group chemistry allow for more efficient synthesis with fewer steps.
3Ease of manufacture
If conventional synthesis approaches are used, then standard procedures can be applied, but β-methyl glucoside impurities are generated
Solution Approach 1:
The patent applies local quality control through specific protecting group placement at critical positions in the disaccharide building blocks. The benzylidene acetal protection at specific hydroxyl positions and the selective benzoyl/acetyl patterning create local chemical environments that direct glycosylation to the correct stereochemistry, preventing β-methyl glucoside impurity formation.
Solution Approach 2:
The patent uses specially designed protecting groups as intermediaries that control the stereochemical outcome of glycosylation reactions. The benzylidene acetal and combined benzoyl/acetyl protecting groups act as intermediaries that guide the formation of only the desired α-anomer, eliminating the need for subsequent purification to remove β-impurities.
4Ease of manufacture
If traditional synthesis routes are followed, then established methodologies can be used, but the process is not scalable to industrial production
Solution Approach 1:
The synthesis is organized into modular building blocks that can be independently synthesized and stored, then coupled in a final scalable step. This segmentation allows for parallel production of building blocks and simplifies scale-up by focusing optimization on the coupling step, making industrial production more feasible.
Solution Approach 2:
The patent implements parameter changes in the form of optimized protecting group chemistry and reaction conditions that enable scalable synthesis. The specific protecting group patterns and glycosylation conditions are designed to be robust and reproducible at large scale, improving scale-up capability while maintaining simplicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new processes enable efficient scale-up of Fondaparinux sodium with higher yields and improved purity, making the synthesis more economically viable and reproducible on an industrial scale while minimizing β-methyl glucoside contamination.
Implementation Method 1
Schmidt glycosylation and milder oxidation procedures
Implementation Method 2
milder oxidation procedures
Data Source
AI summary
The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.